SCHEMBL21890918

SCHEMBL21890918

c1ccc(-n2c(-c3ccc4c(c3)oc3ccccc34)nc3ccccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
HTT P42858 2/20 0.46
MAPK1 P28482 1/20 0.46
PRKACA P17612 1/20 0.45
RPS6KB1 P23443 1/20 0.45
GSK3B P49841 1/20 0.45
ROCK1 Q13464 1/20 0.45
GRIA1 P42261 1/20 0.45
CACNG8 Q8WXS5 1/20 0.45
CACNG2 Q9Y698 1/20 0.45
PTGER4 P35408 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
RECQL P46063 1/20 0.43
ALDH1A1 P00352 7/20 0.41
PTGS2 P35354 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27418112 0.90 ESR1 (0.44) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL27417997 0.90 ESR1 (0.45) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL21392585 0.88 ESR1 (0.52) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL27417713 0.88 ESR1 (0.41) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL23169743 0.88 ESR1 (0.48) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL15394580 0.88 ESR1 (0.48) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL15446513 0.88 ESR1 (0.48) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL15446516 0.88 ESR1 (0.48) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL15446524 0.88 ESR1 (0.48) ESR1ESR2HTTMAPK1PRKACA
SCHEMBL20732608 0.87 ESR1 (0.56) ESR1ESR2HTTMAPK1PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230068759-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2023-03-02 US disclosed
US-20200227656-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-16 US disclosed
US-10615349-B2 Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200227656-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES SUN2, STAU1, HELZ ESR1 2566/4885ESR2 3281/4885HTT 96/4885
US-20230068759-A1 DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES SUN2, STAU1, HELZ ESR1 2566/4885ESR2 3281/4885HTT 96/4885
US-10615349-B2 Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues SUN2, STAU1, HELZ ESR1 2566/4885ESR2 3281/4885HTT 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.